Skip to Main Navigation

Supporting Effective Universal Health Coverage in Argentina

Development Objective

The Development Objective of the proposed Project would be to: (i) increase effective and equitable coverage of key health services provided to the eligible population; and (ii) increase the institutional capacity of the MSN and MSPs to implement mechanisms for an integrated delivery system.

Key Details

Project Details

  • P163345

  • Closed

  • Vanina Camporeale , Marvin Ploetz

  • Argentine Republic

  • Argentina

  • July 12, 2017

  • (as of board presentation)

    May 18, 2018

  • December 17, 2018

  • US$ 300.00 million

  • B

  • Not Applicable

  • April 30, 2025

  • TBD

  • BANK APPROVED

  • May 5, 2024

  • Notes

Finances

Financing Plan (US$ Millions)

No data available.
Financier Commitments
Borrower/Recipient 140.43
International Bank for Reconstruction and Development 300.00

Total Project Financing (US$ Millions)

Product Line IBRD/IDA
IBRD Commitment 300.00
IDA Commitment N/A
IBRD + IDA Commitment 300.00
Lending Instrument
Grant Amount N/A
Total Project Cost** 440.43

Summary Status of World Bank Financing (US$ Millions) as of June 30, 2025

Download:
No data available.
Financier Approval Date Closing Date Principal Disbursed Repayments Interest, Charges & Fees

Detailed Financial Activity as of June 30, 2025

Download:
No data available.
Period Financier Transaction Type Amount (US$)
Apr 15, 2022 IBRD-92220 Int Charges 548,933.75
Apr 15, 2022 IBRD-92220 Int Charges 44,409.25
Apr 15, 2022 IBRD-92220 Int Charges 1,371.53
Jun 15, 2022 IBRD-88530 Loan Disb 3,875,097.50
Aug 26, 2021 IBRD-92220 Loan Disb 625,000.00
Aug 26, 2021 IBRD-92220 Fee Charges 625,000.00
Oct 20, 2021 IBRD-88530 Loan Disb 9,143,433.00
Oct 22, 2021 IBRD-92220 Loan Disb 47,705,968.00
Oct 1, 2021 IBRD-88530 Int Charges 108,330.07
Oct 1, 2021 IBRD-88530 Int Charges 1,346,220.20
Apr 1, 2021 IBRD-88530 Int Charges 1,135,032.00
Apr 1, 2021 IBRD-88530 Int Charges 25,383.68
Apr 1, 2021 IBRD-88530 Int Charges 127,981.92
Dec 19, 2022 IBRD-92220 Loan Disb 20,755,880.00
Oct 1, 2023 IBRD-88530 Int Charges 70,406.98
Apr 15, 2024 IBRD-92220 Int Charges 9,584.37
Mar 25, 2020 IBRD-88530 Loan Disb 14,112,376.00
Aug 1, 2019 IBRD-88530 Loan Disb 21,837,156.00
Apr 1, 2019 IBRD-88530 Int Charges 8,509.38
Apr 1, 2019 IBRD-88530 Int Charges 92,234.59
Apr 1, 2020 IBRD-88530 Int Charges 350,195.00
Apr 1, 2020 IBRD-88530 Int Charges 125,562.98
Apr 1, 2020 IBRD-88530 Int Charges 212,556.95
Apr 1, 2020 IBRD-88530 Int Charges 9,123.74
Apr 1, 2020 IBRD-88530 Int Charges 134,011.95
Oct 1, 2019 IBRD-88530 Int Charges 4,753.75
Oct 1, 2019 IBRD-88530 Int Charges 365,963.60
Oct 1, 2019 IBRD-88530 Int Charges 9,123.74
Aug 6, 2020 IBRD-88530 Loan Disb 34,230,440.00
Sep 8, 2020 IBRD-88530 Loan Disb 78,229,024.00
Oct 1, 2020 IBRD-88530 Int Charges 674.77
Oct 1, 2020 IBRD-88530 Int Charges 7,694.66
Oct 1, 2020 IBRD-88530 Int Charges 303,741.88
Oct 1, 2020 IBRD-88530 Int Charges 17,014.25
Oct 1, 2020 IBRD-88530 Int Charges 371,022.12
Apr 12, 2021 IBRD-88530 Loan Disb 22,145,932.00
Jul 2, 2021 IBRD-88530 Loan Disb 3,430,046.50
Apr 1, 2021 IBRD-88530 Int Charges 61,346.57
Apr 1, 2021 IBRD-88530 Int Charges 153,365.60
Dec 2, 2020 IBRD-88530 Loan Disb 41,893,340.00
Apr 15, 2022 IBRD-92220 Int Charges 1,371.53
Oct 15, 2022 IBRD-92220 Int Charges 6,297.83
Oct 15, 2022 IBRD-92220 Int Charges 2,211,790.20
Sep 1, 2022 IBRD-92220 Loan Disb 20,897,316.00
Dec 22, 2021 IBRD-88530 Loan Disb 3,541,039.50
Dec 17, 2018 IBRD-88530 Loan Disb 750,000.00
Dec 17, 2018 IBRD-88530 Fee Charges 750,000.00
May 18, 2018 IBRD-88530 Loan Commitment 300,000,000.00
Mar 30, 2021 IBRD-92220 Loan Commitment 250,000,000.00
Apr 1, 2024 IBRD-88530 Int Charges 2,688.66
Apr 1, 2024 IBRD-88530 Int Charges 194,214.16
Apr 1, 2024 IBRD-88530 Int Charges 57,182.65
Apr 1, 2024 IBRD-88530 Int Charges 8,732,916.00
Dec 21, 2023 IBRD-88530 Loan Disb 1,476,441.80
Dec 21, 2023 IBRD-92220 Loan Disb 27,778,646.00
Aug 2, 2024 IBRD-88530 Loan Disb 614,095.80
Aug 7, 2024 IBRD-88530 Loan Disb 1,259,760.50
Jul 12, 2024 IBRD-88530 Loan Disb 71,500.00
Apr 1, 2022 IBRD-88530 Int Charges 91,295.64
Apr 1, 2022 IBRD-88530 Int Charges 1,364,230.40
Apr 29, 2022 IBRD-88530 Loan Disb 7,177,971.00
May 31, 2022 IBRD-92220 Loan Disb 27,069,120.00
Jun 23, 2022 IBRD-92220 Loan Disb 33,039,542.00
Apr 15, 2022 IBRD-92220 Int Charges 225,144.31
Apr 1, 2023 IBRD-88530 Int Charges 313,268.10
Apr 1, 2023 IBRD-88530 Int Charges 74,338.44
Apr 1, 2023 IBRD-88530 Int Charges 6,045,133.50
Apr 1, 2023 IBRD-88530 Int Charges 74,338.44
Oct 1, 2022 IBRD-88530 Int Charges 3,320,998.00
Oct 1, 2022 IBRD-88530 Int Charges 78,114.13
Oct 15, 2022 IBRD-92220 Int Charges 152,049.55
Dec 21, 2021 IBRD-92220 Loan Disb 34,490,380.00
Aug 21, 2023 IBRD-88530 Loan Disb 6,672,923.50
Aug 21, 2023 IBRD-92220 Loan Disb 24,894,728.00
Apr 15, 2023 IBRD-92220 Int Charges 78,194.65
May 12, 2023 IBRD-92220 Loan Disb 11,971,442.00
May 12, 2023 IBRD-88530 Loan Disb 1,697,778.50
Apr 15, 2023 IBRD-92220 Int Charges 19,633.75
Apr 15, 2023 IBRD-92220 Int Charges 258,031.30
Apr 15, 2023 IBRD-92220 Int Charges 4,923,934.50
Apr 15, 2023 IBRD-92220 Int Charges 6,297.83
Apr 15, 2023 IBRD-92220 Int Charges 90,787.58
Oct 15, 2023 IBRD-92220 Int Charges 44,982.03
Oct 15, 2023 IBRD-92220 Int Charges 24,221.59
Oct 15, 2023 IBRD-92220 Int Charges 27,173.30
Oct 15, 2023 IBRD-92220 Int Charges 59,619.25
Oct 15, 2023 IBRD-92220 Int Charges 6,613,833.00
Sep 6, 2023 IBRD-88530 Loan Disb 4,758,196.00
Sep 6, 2023 IBRD-92220 Loan Disb 771,976.00
Apr 1, 2024 IBRD-88530 Int Charges 54,493.99
Apr 15, 2024 IBRD-92220 Int Charges 325,131.80
Apr 15, 2024 IBRD-92220 Int Charges 12,747.73
Apr 15, 2024 IBRD-92220 Int Charges 3,582,120.50
Apr 15, 2024 IBRD-92220 Int Charges 5,187,684.00
Aug 5, 2024 IBRD-88530 Loan Disb 157,470.06
Aug 9, 2024 IBRD-88530 Loan Disb 22,083,944.00
Oct 1, 2023 IBRD-88530 Int Charges 139,363.73
Oct 1, 2023 IBRD-88530 Int Charges 70,406.98
Oct 1, 2023 IBRD-88530 Int Charges 7,552,278.00

Footnotes

Ratings

IMPLEMENTATION RATINGS

Name Review Date
Progress towards achievement of PDO Satisfactory 2025-04-28
Financial Management Satisfactory 2025-04-28
Monitoring and Evaluation Satisfactory 2025-04-28
Overall Implementation Progress (IP) Satisfactory 2025-04-28
Procurement Moderately Satisfactory 2025-04-28
Project Management Satisfactory 2025-04-28

COMPLETION RATINGS

No data available.

INDEPENDENT EVALUATION RATINGS

No data available.

Results Framework

PROJECT DEVELOPMENT OBJECTIVE INDICATORS

INDICATORBASELINECURRENTTARGET
  • Percentage of eligible population with effective health coverage.Value26.7033.0035.00
    DateSeptember 29, 2017December 31, 2023December 31, 2023
    Comment
  • Percentage of eligible population enrolled and assigned to a health facility, for continuous care (“empaneled”).Value0.0012.0012.00
    DateOctober 31, 2017December 31, 2023December 31, 2023
    Comment
  • Percentage of eligible adults with hypertension that are diagnosed, in regions with poorest health outcomesValue0.0021.5018.00
    DateOctober 31, 2017August 31, 2023December 31, 2023
    Comment

INTERMEDIATE RESULTS INDICATORS

INDICATORBASELINECURRENTTARGET
  • Percentage of eligible pregnant women with early antenatal care.Value14.7038.8022.00
    DateSeptember 29, 2017August 31, 2022December 31, 2023
    Comment
  • Percentage of participating provinces implementing the agreed Interoperability Plan for Information Systems.Value0.0091.7037.50
    DateOctober 31, 2017December 31, 2023December 31, 2023
    Comment
  • Percentage of participating provinces successfully meeting their annual IPP goals.Value61.0086.9078.00
    DateDecember 30, 2016December 31, 2023December 31, 2023
    Comment
  • Percentage of eligible women 25 - 64 years of age with at least one cervical cancer screening according to defined protocols.Value19.6017.6024.00
    DateApril 28, 2017September 30, 2023December 31, 2023
    Comment
  • Percentage of health facilities with service delivery capacity strengthened for key lines of care, through medical equipment provision.Value0.0022.7030.00
    DateOctober 31, 2017December 31, 2021December 31, 2023
    Comment
  • Percentage of participating provinces implementing actions to disseminate information on the Project’s grievance redress mechanism.Value54.0083.3079.00
    DateDecember 30, 2016December 31, 2023December 31, 2023
    Comment
  • Percentage of eligible population with hypertension under treatment.Value0.0010.1015.00
    DateNovember 30, 2017August 31, 2023December 31, 2023
    Comment
  • Percentage of participating public health facilities billing to the social security institutions.Value25.0054.1028.00
    DateOctober 31, 2017December 31, 2023December 31, 2023
    Comment
  • Percentage of participating provinces with reported health services for selected key lines of care.Value0.00100.0021.00
    DateDecember 6, 2017September 30, 2023December 31, 2023
    Comment
  • Percentage of primary health care providers georreferenced and with a catchment area defined.Value0.0056.4060.00
    DateOctober 31, 2017December 31, 2023December 31, 2023
    Comment